BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2328882)

  • 21. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pepsinogen I in childhood Helicobacter pylori gastritis: its relation to mucosal peptic activity.
    Yahav J; Oderda G; Diver-Haber A; Fradkin A; Keller N; Altare F; Ansaldi N; Jonas A
    Isr J Med Sci; 1996 Jan; 32(1):56-9. PubMed ID: 8550350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen].
    Pustorino S; Turiano S; Pizzimenti C; Calipari G; Federico G; D'Amico G; Sinopoli C; Martinez P; Guerrisi O; Luzza G
    Clin Ter; 1994 Oct; 145(10):277-81. PubMed ID: 7820984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis.
    Inoue M; Kobayashi S; Matsuura A; Hamajima N; Tajima K; Tominaga S
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):261-3. PubMed ID: 9521444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
    Samloff IM; Varis K; Ihamaki T; Siurala M; Rotter JI
    Gastroenterology; 1982 Jul; 83(1 Pt 2):204-9. PubMed ID: 7084603
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum pepsinogens I and II and gastric acid output: effect of gastritis.
    Samloff IM; Varis K; Ihamäki T; Siurala M; Rotter JI
    Prog Clin Biol Res; 1985; 173():129-38. PubMed ID: 3983191
    [No Abstract]   [Full Text] [Related]  

  • 27. Stereological investigations on human gastric mucosa: I. Normal oxyntic mucosa.
    Helander HF; Leth R; Olbe L
    Anat Rec; 1986 Nov; 216(3):373-80. PubMed ID: 3789420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum pepsinogen I levels and acid secretion in Helicobacter pylori associated enlarged fold gastritis.
    Yasunaga Y; Shinomura Y; Kanayama S; Miyazaki Y; Bonilla Palacios JJ; Matsuzawa Y
    Ital J Gastroenterol; 1996; 28(8):457-61. PubMed ID: 9032589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pepsinogen gastrin mesor ratio: a potential simple marker for gastric secretory function.
    Tarquini B; Benvenuti M; Cavallini V; Cecchettin M; Romano S; Sensi G
    Chronobiologia; 1984; 11(1):11-7. PubMed ID: 6723472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between gastric secretion and type of early gastric carcinoma.
    Yoshihara M; Haruma K; Sumii K; Watanabe C; Kiyohira K; Kawaguchi H; Tanaka S; Kajiyama G
    Hiroshima J Med Sci; 1995 Sep; 44(3):79-82. PubMed ID: 8567316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The analysis of the gastric mucosa by computerized densitometry].
    Valenzuela M; Martín Ruiz JL; Caballero AM; Alvarez de Cienfuegos I; Nogales FF; Peña JF
    Gastroenterol Hepatol; 1995 Nov; 18(9):449-56. PubMed ID: 8521220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
    Stemmermann GN; Samloff IM; Hayashi T
    Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.